Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects

• Aysin Tulunay Virlan,
• Giacomo Cafaro,
• Flavia Sunzini,
• Yannick Degboe,
• Maria-Ioanna Christodoulou,
• Maria-Ioanna Christodoulou

Affiliations

Aysin Tulunay Virlan

School of Infection & Immunity, University of Glasgow, Glasgow, United Kingdom

Giacomo Cafaro

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy

Flavia Sunzini

School of Infection & Immunity, University of Glasgow, Glasgow, United Kingdom

Yannick Degboe

Rheumatology Centre, Toulouse University Hospital and University Toulouse III, Toulouse, France

Maria-Ioanna Christodoulou

School of Infection & Immunity, University of Glasgow, Glasgow, United Kingdom

Maria-Ioanna Christodoulou

Tumor Immunology and Biomarkers Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus